COMMUNIQUÉ DE PRESSE publié le 17/01/2024 à 14:15, il y a 1 année 3 mois AL STOCK TRADES Breaks New Ground: Launches Global Neurosurgical Alliance to Revolutionize Neurosurgical Collaboration Worldwide AL STOCK TRADES, a leading figure in stock analysis, is venturing into the nonprofit sector with the establishment of the Global Neurosurgical Alliance (GNA) to promote collaboration in neurological research and education. With a focus on improving patient care in low-GDP countries, this initiative represents a pioneering effort in democratizing medical research and advancing global health. The impressive trajectory of AL STOCK TRADES and GNA reflects a revolutionary blend of financial expertise and humanitarian ambition, setting new standards in global health and education. Financial Expertise AL STOCK TRADES Global Neurosurgical Alliance Neurological Research Low-GDP Countries
Publié le 17/04/2025 à 19:10, il y a 1 heure 1 minute Covivio - Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale Mixte des actionnaires du 17 avril 2025
Publié le 17/04/2025 à 19:10, il y a 1 heure 1 minute Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 17 April 2025
Publié le 17/04/2025 à 18:11, il y a 2 heures Feu vert de l’Autorité de la Concurrence pour l’acquisition du Groupe Pierre MARTINET
Publié le 17/04/2025 à 18:06, il y a 2 heures 4 minutes Chiffre d'Affaires Annuel de l'Exercice 2024/2025
Publié le 17/04/2025 à 18:00, il y a 2 heures 11 minutes Accor renforce son réseau Amériques avec 17 nouveaux hôtels
Publié le 17/04/2025 à 18:20, il y a 1 heure 51 minutes Kestrel Partner Centerra to Continue Exploration at Kestrel’s QCM Gold Property
Publié le 17/04/2025 à 17:45, il y a 2 heures 26 minutes SMX Enters ASEAN Region: A Strategic Milestone Leap Toward a Global Circular Plastics Future
Publié le 17/04/2025 à 17:20, il y a 2 heures 51 minutes Gamehost Announces Regular Monthly Dividend for February
Publié le 17/04/2025 à 15:00, il y a 5 heures 11 minutes Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress
Publié le 17/04/2025 à 19:00, il y a 1 heure 11 minutes u-blox shareholders approve all motions proposed by the Board of Directors at the Ordinary General Meeting 2025